Syn-One
This is the type of sample collected for the Syn-One Test.
What is a skin biopsy?
The founders of CND Life Sciences include two neurologists and a specialist in autonomic and peripheral nerve disorders, among them Roy Freeman MD, Christopher Gibbons MD, and this neurologist.
Who is Todd Levine MD?
This company, founded in 2017 as Cutaneous NeuroDiagnostics, uses skin biopsies to help diagnose neurodegenerative diseases.
What is CND Life Sciences, Inc.?
This is the first step in the RCM workflow and ensures that patient demographic and payer data are correct before the Syn-One Test can be billed.
What is patient registration / insurance verification?
This is the most important thing to confirm when speaking with a patient about their Syn-One Test bill, because it ensures you are discussing information with the right person.
What is verifying patient identity?
Because the Syn-One Test uses skin punch biopsies, providers must ensure the correct use of these procedural code types.
What are biopsy CPT codes?
This founder, now Senior Scientific Advisor, is a Harvard professor and expert in autonomic and peripheral nerve disorders.
Who is Roy Freeman, MD?
CND
What is the acronym for Cutaneous Neurodiagnostic?
Obtaining coverage for the Syn-One Test sometimes requires submitting this payer-specific review to determine if the plan will cover the service.
What is a prior authorization?
Financial Assistance, Prompt Pay, Self Pay, Care Credit, Payment Plan
What are the 5 patient AR options?
88314 and 88350
What are the 2 commonly denied add on codes?
This founder previously founded the Corinthian Reference Lab (CRL), which processed over 50,000 skin biopsies before CND was created.
Who is Todd D. Levine, MD?
The CEO of CND Life Sciences, who joined in 2020 and has over 25 years of experience in diagnostics, is this person.
Who is Rick (Richard) Morello?
These entities represent the majority of claim denials for the Syn-One Test due to medical policy limitations or insufficient documentation.
What are commercial payers?
A key statement staff can use: “Even though we are out of network, we still do this on your behalf so your insurance has an opportunity to contribute.”
What is submit claim and explore financial assistance options?
In a 2024 JAMA publication, the Syn-One Test demonstrated approximately this percentage of overall sensitivity for detecting abnormal alpha-synuclein.
What is 95.5%?
These two founders originally discussed the presence of phosphorylated alpha-synuclein in skin nerves at a conference poster, sparking the idea for CND.
Who are Roy Freeman, MD and Christopher Gibbons, MD?
CND Life Sciences is headquartered in this Arizona city, where it also operates a CLIA-certified and CAP-accredited laboratory.
What is Scottsdale, Arizona?
When a claim for the Syn-One Test denies for “not a covered service,” the RCM team initiates this type of follow-up process to request a payer reconsideration.
What is a claim appeal?
A key patient-friendly practice at CND: If insurance denies the claim, RCM staff can step in to help the patient to challenge the decision by submitting one of these.
What is an appeal?
The Syn-One Test targets diseases known as “synucleinopathies,” which includes Parkinson’s disease and this dementia subtype characterized by alpha-synuclein deposits.
What is dementia with Lewy bodies?
This founder is the Chief Scientific Officer and helped establish the neurocutaneous skin biopsy lab at Beth Israel Deaconess Medical Center.
Who is Christopher Gibbons, MD?
In 2023, CND's lab earned this accreditation from the College of American Pathologists, signifying high standards in lab medicine.
What is CAP accreditation?
This standard medical coding system is used to report the procedure portion of the Syn-One Test biopsy to payers.
What is CPT coding?
Patient might ask lots of questions about the Syn-One Test, so staff should respond with patience and these 2 things.
What are empathy and clear explanations?